Skip to content

A study to compare the effectiveness of 2% dill (Anethum graveolens) gel used along with scaling and root planing in patients with moderate gum disease.

Comparative Evaluation Of Locally Delivered 2% Anethum Graveolens Gel As An Adjunct To Scaling And Root Planing In Stage II Grade A Periodontitis: A Split Mouth Randomised Control Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104733
Enrollment
31
Registered
2026-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: 2% Anethum graveolens gel: After performing scaling and root planing, 2% Anethum graveolens gel will be locally delivered into the periodontal pocket using a blunt needle tip until the

Sponsors

Dr Ruta Bhave
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with history of underlying systemic disease, pregnant or lactating women, patients who had undergone any nonsurgical periodontal therapy in the past 6 months, Patients who have known allergies, patients who are chronic smokers

Exclusion criteria

Exclusion criteria: Patients with history of underlying systemic disease. Pregnant or lactating women. Patients who had undergone any nonsurgical periodontal therapy in the past 6 months. Patients who have known allergies. Patients who are chronic smokers.

Design outcomes

Primary

MeasureTime frame
Reduction in Probing Pocket Depth (PPD), Gain in Clinical Attachment Level (CAL), Reduced Bleeding on probingTimepoint: 1 week, 3 and 6 months.

Secondary

MeasureTime frame
Change in Modified Sulcular Bleeding Index (mSBI) from baseline to 1 week, 3 months and 6 months.Timepoint: 1 week, 3 months and 6 months

Countries

India

Contacts

Public ContactDr Ruta Bhave

KAHERs KLE VK Institute of Dental Sciences, Belagavi

renukametgud@gmail.com9448920880

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026